Cancer Immunotherapy Using Tumor Cryoablation
- 16 December 2013
- journal article
- review article
- Published by Taylor & Francis in Immunotherapy
- Vol. 6 (1) , 85-93
Abstract
Cryoablation is increasingly being used as a primary treatment for localized cancers and as a salvage therapy for metastatic cancers. Anecdotal clinical reports and animal experiments have confirmed an induction of systemic antitumor immune response by tumor cryoablation. To capitalize on the stimulatory effects of cryoablation for cancer immunotherapy, this response must be intensified using other immunomodulatory agents. This article reviews the preclinical and clinical evidence and discusses the mechanism of the antitumor immune response generated by cryoablation. The rationale and evidence behind several immunotherapy approaches that can be combined with cryoablation to devise a cryoimmunotherapeutic strategy with a potential to impact the progression of metastatic disease are described.Keywords
This publication has 77 references indexed in Scilit:
- Antibody-Based Immunotherapy of CancerCell, 2012
- Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destructionVaccine, 2012
- Tumor Evasion from T Cell SurveillanceBioMed Research International, 2011
- A dose- and time-controllable syngeneic animal model of breast cancer microcalcificationBreast Cancer Research and Treatment, 2009
- Cyclophosphamide Unmasks an Antimetastatic Effect of Local Tumor CryoablationThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximabBlood, 2009
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Imiquimod Enhances the Systemic Immunity Attained by Local Cryosurgery Destruction of Melanoma LesionsJournal of Investigative Dermatology, 2007
- Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunityBritish Journal of Cancer, 2006
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004